Yazar "Nagler, Arnon" için listeleme
-
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study
Lugtenburg, Pieternella; Avivi, Irit; Berenschot, Henriette; Ilhan, Osman; Marolleau, Jean Pierre; Nagler, Arnon; Pfreundschuh, Michael (Ferrata Storti Foundation, 2017)Intravenous rituximab plus chemotherapy is standard treatment for diffuse large B-cell lymphoma. A subcutaneous formulation of rituximab is expected to simplify and shorten drug preparation and administration, and to reduce ...